RT Journal Article
SR Electronic
T1 Thyroid Follicular Epithelial Cell-Derived Cancer: New Approaches and Treatment Strategies
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP jnmt.120.257105
DO 10.2967/jnmt.120.257105
A1 Julie Bolin
YR 2021
UL http://tech.snmjournals.org/content/early/2021/07/09/jnmt.120.257105.abstract
AB Thyroid follicular epithelial cell-derived cancer includes papillary, follicular, and anaplastic thyroid carcinomas. Although thyroid cancer incidence has increased over the past thirty years, there has not been a significant increase in patient mortality. Utilization of increasingly sensitive detection methods such as high resolution imaging have enabled earlier detection and better characterization of the thyroid malignancies. In the past several years, researchers have evaluated genetic mutations promoting thyroid carcinogenesis and oncogenesis. The identification of genetic mutations is not only important in understanding tumor initiation and progression but also serve as potential diagnostic or prognostic indicators and therapeutic molecular targets.